Submission of Annual Report for Financial Year 2024-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hemo Organic Limited has filed its 33rd Annual Report for FY 2024-25 with BSE and issued the AGM notice. The 33rd AGM will be held on Monday, 29th September 2025 at 4:00 PM through video conferencing (VC/OAVM). Ordinary business items include adoption of audited FY25 financial statements and re-appointment of Managing Director Mr. Vishwambar Kameshwar Singh, who retires by rotation. Special business items include regularization of Mr. Deepak Ashokkumar Rochani as Independent Director (appointed 27 June 2025, term till 26 June 2030) and four special resolutions seeking shareholder approval for borrowing powers up to Rs. 100 crore under Section 180(1)(c), creating charges on company assets, authorizing loans/investments up to Rs. 100 crore under Section 186, and approving loans to directors/related parties up to Rs. 100 crore under Section 185. The cut-off date for e-voting eligibility is 22nd September 2025, with remote e-voting running from 26th to 28th September 2025 via NSDL.
Shareholders should vote on several capital-structure related resolutions that significantly raise the company's borrowing and lending capacity (up to Rs. 100 crore each), which could increase financial leverage and related-party exposure. Re-appointment of the existing Managing Director and addition of a finance-focused Independent Director signals board continuity with strengthened capital markets expertise.